Xarelto Blood Thinner Lawsuit: Behind The Scene of Legal Battle

The Xarelto blood thinner lawsuit was a serious case encompassing the severe side effects of a medicine that caused many victims to sue the company. The side effects can cause death. Here is complete information about the case as well as the settlement. Then, take a look closer! 

What is Xarelto Blood Thinner?

Before going deeper into the Xarelto blood thinner lawsuit, you should understand about Xarelto, such as its use and its side effects before it was sued by many people. 

Xarelto or rivaroxaban is a blood thinner medicine approved by the FDA in 2011. Xarelto is one of the class medications called factor Xa inhibitors.

The prescription is used to reduce the risk of blood clots, treat the blood clots in the veins of your legs or lungs, and reduce and prevent blood clots. Moreover, this medicine also can be used to help prevent stroke and lower the risk of heart attack and death in adults with coronary disease. 

Furthermore, children can consume this medicine to prevent and treat DVT and PE from happening again with some conditions. This medicine also can help you to prevent DVT or PE from coming back after receiving treatment for blood clots for at least 6 months.

However, this medicine needs a doctor’s advice and prescription because your doctor should consider your condition and think that the medicine is more beneficial than the side effects. 

This medication can cause serious effects. For example, it can worsen your bleeding if it affects your blood clotting protein too much. You should go to your doctor immediately if there are any signs of serious bleeding. The cases include nosebleeds, weakness, unusual pain, bruising, and many more.

Therefore, this medication can be catastrophic if there is no prevention action followed after there are various signs. This is the reason why many people file a complaint to the company and sue them. Also, that is what we call the Xarelto blood thinner lawsuit.

The Background of Xarelto Blood Thinner Lawsuit

Bayer AG and Johnson & Johnson have settled more than 25,000 lawsuits in the United States. People alleged that their blockbuster blood thinner Xarelto causes unstoppable bleeding. Also, in some cases, the fatal bleeding allegation settlement can be as high as $775 million. 

The Xarelto blood thinner lawsuits claimed that the drugmakers failed to warn about the bleeding risks, which could have been prevented. Moreover, doctors and patients have not been provided with clear information about the side effects. 

Some of the injuries reported in the lawsuits include internal bleeding, wound leakage, and infections.

However, it has been associated with side effects such as numb or tingling muscles, loss of ability to control movement, abnormal liver function, and many more. Bleeding caused by Xarelto can be irreversible, leading to hospitalizations and even catastrophic for the body.

Despite the settlement, Bayer and Johnson & Johnson continue to maintain that the claims are without merit. The settlement allows the companies to avoid the distraction and significant cost of ongoing litigation. 

Most complaints got grouped in a federal court down in New Orleans. They picked three cases for what they call bellwether trials. It aimed at helping to determine the range of damages and define settlement options. The companies won those 3 trials in 2017 and were also cleared of liability in three other state court trials in 2018.

Settlement of Xarelto Blood Thinner Lawsuit

The value of the Xarelto Blood Thinner Lawsuit, typical in mass tort claims, fluctuates during the discovery process. Additionally, due to the wide range of injuries, from minor to fatal or disabling, settlement amounts are likely to vary. Multiple settlement tiers are based on how bad the injuries are.

Many Xarelto blood thinner lawsuit cases worth millions are limited by state law. Some other cases involve severe injuries, and juries think that if the drug company has errors, they could handle some compensation. 

Historically, mass tort cases like the Xarelto litigation often conclude with a global settlement. Plaintiffs usually complete a fact sheet outlining their claim, and the settlement occurs after a few trials provide insights into the cases’ true value. In some cases, drug companies settle everything before it goes to trial

The anticipated settlement value for an average Xarelto case is approximately $75,000 to $300,000 for cases involving serious injury or death. This estimate considers past settlements in similar mass tort contexts and recent litigations involving Bayer, Johnson & Johnson.

As of September 2019, the average is approximately $31,000 per case. The future will reveal how many cases involve minor injuries and the settlement values for death and serious injury cases. Some cases might opt out if settlement values are inadequate, while others may not qualify for the settlement.

However, the settlement is just an approximation for the people. The number of settlements could be higher or lower. Moreover, the settlement is based on the injuries that can be different in each person.

How Long Until The Cases Settle?

They already have the global settlement agreement in the bag for the Xarelto blood thinner lawsuit. However, some cases can be resolved after several trials. Before the settlement, Bayer and the plaintiff’s attorneys need to have some discussion to get the settlement value of this case.

The global settlement can be a problem for Bayer because it can result in an existential threat to the company. These conditions led Bayer to clean up other litigation loose ends in a swift movement.

That is How the Xarelto Case Is Going!

The Xarelto Blood Thinner lawsuit resulted in a significant settlement to pay $775 million to resolve around 25,000 cases alleging serious side effects of the medicine. Moreover, the lawsuit has highlighted the importance of clear warning labels and the risks of consuming the medicine, especially Xarelto.

The FDA has approved that there is an antidote to prevent the severe side effects of the drug. Also, patients who were not part of the settlement can still file a lawsuit against the manufacturers. So, do you think this settlement is fair for both parties?